Barron will stay on GSKs board as a non-executive director providing advice on research and development. Back in 2017 Wood first came to GSK from Pfizer to work as a senior vice president of medicinal research and technology.
Ccaim Inaugural Event
Tony Wood appointed Chief Scientific Officer designate GSK.
. COVID-19 Our response to COVID-19. Tony Wood Senior Vice President Medicinal Science and Technology of GSK said. The Directors of the Institute will be Professor John Todd Director of the Wellcome Centre for Human Genetics and Dr Tony Wood SVP Medicinal Science and Technology at GSK.
He been instrumental in delivering new product launches including Nucala. Wood will succeed Dr Hal Barron as CSO. London UK Tony Wood to assume full accountability for GSK RD in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support RD.
In the past few years under Hals leadership we have made enormous progress to strengthen the pipeline and put in place an RD approach that can improve the efficiency and success of medicine and vaccine development. GlaxoSmithKline GSK has appointed Tony Wood as Chief Scientific Officer CSO designate. No credit card required.
A completely new way of collaborating will be established where research teams will have both GSK and University members including secondments between both institutions. Before joining GSK in October 2017 he was head of Worldwide Research. LONDON UK GlaxoSmithKline plc GSK today announced the appointment of Tony Wood as Chief Scientific Officer CSO designate.
Tony Woods Email Phone Number Senior Vice President Medicinal Science and Technology GSK View Tonys Email Phone Its Free 5 free lookups per month. Tony Wood to assume full accountability for GSK R. GlaxoSmithKline plc GSK today announced the appointment of Tony Wood as Chief Scientific Officer CSO designate.
January 20 2022 A A Tony Wood to assume full accountability for GSK RD in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support RD GlaxoSmithKline plc GSK today announced the appointment of Tony Wood as Chief Scientific Officer CSO designate. Skip to Content Skip to Search. Tony Wood - Biography Since joining GSK in 2017 as Senior Vice President Medicinal Science and Technology Tony has been responsible for all science and technology platforms supporting the discovery clinical development and delivery of new medicines across GSK.
London UK Tony Wood to assume full accountability for GSK RD in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support RD. Location United Kingdom Work Senior Vice President Medicinal Science and Technology GSK Senior Vice President Platform Technology and Science GSK. As of 1 August 2022 Wood will assume full accountability for RD from current CSO Dr Hal Barron at which time Dr Barron will become a Non-Executive Director on GSKs Board with additional responsibilities to support RD.
Tony was closely involved with the UK Governments COVID-19 planning notably establishing the GSKAstraZenecaCambridge University testing facility at the Universitys Anne McLaren Laboratory. - Tony Wood to assume full accountability for GSK RD in August 2022 - Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support. GlaxoSmithKline GSK has announced its plans to appoint Tony Wood as chief scientific officer CSO designate.
Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support R. Tony Wood is Senior Vice President of Medicinal Science Technology GSK. Behind the science Explore innovations in medicines vaccines and consumer healthcare from inside and outside.
Tony Wood will be the new chief scientific officer CSO for GlaxoSmithKline GSK as of August. He will be replaced as GSKs chief scientific officer by Tony Wood on 1. Tony was closely involved with the UK Governments COVID-19 planning notably establishing the GSKAstraZenecaCambridge University testing facility at the Universitys Anne McLaren Laboratory.
He is a member of the RD Leadership Team reporting to Hal Barron President RD. Tony Wood appointed CSO Designate GSK 070057 19 Jan 2022 - GSK PLC - News article - Regulatory News Service. Tony Wood appointed Chief Scientific Officer designate GSK.
May 2 2022. I am honoured to have been asked to lead GSKs RD. The appointment will see Wood take full responsibility for research and development across GSKs pipeline and portfolio beginning on 1 August 2022.
His position then was to supervise. His role will be focused on research and development throughout GSKs process and portfolio. GSK logo linking to the homepage.
Tony Wood appointed Chief Scientific Officer designate GSK For media and investors only Issued. Tony is a highly respected scientist and one of the worlds pre-eminent medicinal chemists with more than 30 years of experience working across diverse disciplines of RD to deliver innovative medicines. Adrestia has shown that synthetic viability can rescue diseased or dying cells and is a natural extension of our work with synthetic lethality to find novel medicines.
Tony was appointed Chief Scientific Officer designate on 19 January 2022 and will assume full accountability for GSK RD in August 2022. Tony Wood appointed Chief Scientific Officer designate GSK January 18 For media and investors only Issued. Tony will assume full accountability for Research and Development RD from current CSO Dr Hal Barron on 1 August 2022 after which Hal will remain on GSKs Board and become a Non-Executive Director with additional responsibilities.
Tony Wood Chief Scientific Officer designate said.
Meet The Medchemcomm Editorial Board Medchemcomm Rsc Publishing Doi 10 1039 C0md90002h
Senior Vice President Of Gsk Talks Drug Discovery At Imse S First Annual Lecture Imperial News Imperial College London
Dove Posm On Behance Posm Retail Design Display Exhibition Display Stands
Dr Tony Wood British Pharmacological Society
Tony Wood Chief Scientific Officer Gsk Linkedin
Tony Wood Chief Scientific Officer Gsk Linkedin
Tony Wood To Succeed Dr Hal Barron As Chief Scientific Officer At Glaxosmithkline R D Europawire Eu The European Union S Press Release Distribution Newswire Service
Ian E D Smith Medicinal Chemist Gsk Linkedin
Tony Wood
Innovation Gsk Us
Meet The Medchemcomm Editorial Board Medchemcomm Rsc Publishing Doi 10 1039 C0md90002h
Nuevo Director Cientifico De Gsk Tony Wood
Gsk On Twitter Huge Congrats To Pauline Williams Tony Wood Who Ve Been Elected To Acmedsci S Prestigious Fellowship For Their Outstanding Contributions To Biomedical And Health Science Https T Co Vswhrybojz Https T Co Obfwbbzmxv Twitter
New Look Gsk Faces Moment Of Reckoning As Consumer Business Spins Off Bioworld
Senior Vice President Of Gsk Talks Drug Discovery At Imse S First Annual Lecture Imperial News Imperial College London
Pin On War
Tony Wood Gsk
Tweets With Replies By Gsk Gsk Twitter
Gsk On Twitter Tony Wood Chief Scientific Officer Designate On What Sets Gsk Apart Read More About Today S Announcement Https T Co Akgdgzy11s Https T Co 0ddpr9o73s Twitter